Pfizer Ventures
5 rounds tracked since 12 January 2026.
- Rounds
- 5
- Led
- 2
- Capital in these rounds
- $348M
Sectors
Countries
Rounds
- TwoStep TherapeuticsLeadDevelops peptide-drug conjugates for targeted cancer treatment $62.5MSeries A · 9 Sept
- Flare TherapeuticsDiscovers and develops precision medicines by targeting transcription factors, focusing on prostate cancer. $85MSeries C · 30 Jun
- Oblenio BioLeadDevelops therapies intended to treat autoimmune diseases. $62MSeries B · 27 Jun
- Crossbow TherapeuticsDevelops T-cell engager antibody therapies to treat a broad range of cancers. $77MSeries B · 18 Mar
- Vibrant TherapeuticsDevelops next-generation intelligent therapeutics for solid tumors, including the masked T-cell engager VIB305. $61M12 Jan
Often invests with
The Daily Raise
The day's rounds in your inbox each morning.
Subscribe to The Daily Raise